Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT – Get Free Report) Director Jennifer Straumins sold 100,000 shares of the business’s stock in a transaction on Monday, June 16th. The shares were sold at an average price of $16.23, for a total transaction of $1,623,000.00. Following the completion of the sale, the director now directly owns 934,589 shares of the company’s stock, valued at approximately $15,168,379.47. This trade represents a 9.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Jennifer Straumins also recently made the following trade(s):
- On Friday, June 13th, Jennifer Straumins sold 50,000 shares of Calumet Specialty Products Partners stock. The shares were sold at an average price of $15.08, for a total transaction of $754,000.00.
- On Thursday, June 5th, Jennifer Straumins sold 100,000 shares of Calumet Specialty Products Partners stock. The shares were sold at an average price of $13.17, for a total transaction of $1,317,000.00.
Calumet Specialty Products Partners Stock Performance
NASDAQ CLMT opened at $16.86 on Tuesday. The firm has a market cap of $1.45 billion, a PE ratio of -6.11 and a beta of 0.91. Calumet Specialty Products Partners, L.P. has a one year low of $7.68 and a one year high of $25.29. The firm’s fifty day moving average is $12.25 and its two-hundred day moving average is $15.23.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on CLMT shares. TD Cowen cut shares of Calumet Specialty Products Partners from a “buy” rating to a “hold” rating and reduced their price target for the company from $26.00 to $16.00 in a research report on Tuesday, March 4th. Bank of America started coverage on shares of Calumet Specialty Products Partners in a research report on Tuesday, May 13th. They issued a “buy” rating and a $15.00 price target for the company. Wells Fargo & Company reduced their price target on shares of Calumet Specialty Products Partners from $23.00 to $21.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. UBS Group raised shares of Calumet Specialty Products Partners from a “sell” rating to a “neutral” rating and reduced their price target for the company from $15.00 to $12.00 in a research report on Monday, March 17th. Finally, The Goldman Sachs Group reduced their price target on shares of Calumet Specialty Products Partners from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Wednesday, April 30th. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $18.50.
Get Our Latest Stock Report on Calumet Specialty Products Partners
About Calumet Specialty Products Partners
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Further Reading
- Five stocks we like better than Calumet Specialty Products Partners
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- New Catalysts to Drive NVIDIA’s Stock Price Even Higher
- How to Calculate Stock Profit
- China Market Movers: MCHI, PDD, BIDU Show Bullish Trends
- Canada Bond Market Holiday: How to Invest and Trade
- Palantir Defies Bears, Leads S&P 500 in 2025
Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.